LifeStance Health (LFST) Interest Expenses (2020 - 2026)

LifeStance Health (LFST) has reported Interest Expenses for 7 consecutive years, with $1.8 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Interest Expenses fell 89.13% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $18.3 million (up 66.68% YoY), while the FY2025 annual figure was $124.2 million, up 91.53% from the prior year.
• Interest Expenses declined to $1.8 million in Q1 2026 per LFST's latest filing, from $16.8 million in the prior quarter.
• Across five years, Interest Expenses topped out at $296.9 million in Q1 2023 and bottomed at -$47.2 million in Q4 2023.
• Historically, Interest Expenses has averaged $37.8 million across 5 years, with a median of $6.3 million in 2022.
• On a YoY basis, Interest Expenses climbed as much as 9505.66% in 2023 and fell as far as 1014.7% in 2023.
• LifeStance Health's Interest Expenses stood at $5.2 million in 2022, then sank by 1014.7% to -$47.2 million in 2023, then jumped by 64.49% to -$16.8 million in 2024, then jumped by 199.85% to $16.8 million in 2025, then plunged by 89.3% to $1.8 million in 2026.
• Business Quant data shows LFST's Interest Expenses at $1.8 million in Q1 2026, $16.8 million in Q4 2025, and $41.2 million in Q3 2025.